CompletedNot Applicable

Complete Twelve Month Bone Remodeling With a Bi-phasic Injectable Bone Substitute in Benign Bone Tumors

14 participantsStarted 2011-02

Plain-language summary

The purpose of this study is to assess the ability a injectable bi-phasic ceramic bone substitute to provide bone generation and bone remodeling in patients with benign bone tumors.

Who can participate

Age range7 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients admitted to the hospital for surgical treatment of benign bone lesion requiring bone grafting. Exclusion Criteria: * Patient below 6 years of ageIrreversible coagulopathy or bleeding disorder. Note regarding reversible coagulopathies: Patients on coumarin or other anticoagulants may participate. Investigators should follow routine practices for perioperative discontinuation and re-initiation of anticoagulants; * A pre-existing calcium metabolism disorder (e.g. hypercalcemia).

What they're measuring

bone remodeling according to Neer classification

Timeframe: 12 months after surgery

Trial details

NCT IDNCT02567084

SponsorPoznan University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-12

View on ClinicalTrials.gov More Bone Cyst trials